Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fox EJ et al. - Although cancer genome sequencing will revolutionize certain aspects of personalized care, the value of these studies in facilitating the development of new therapies, their primary goal, seems less promising. Most significantly, however, the cancer genome sequencing strategy, as currently applied, fails to characterize the most relevant genomic features of cancer—the mutational heterogeneity within individual tumors.

Related Articles

DNA methylation of cancer genome
Birth Defects Research, 12/08/09    Relevance Score: 67%%

Copy number variations and cancer susceptibility
Current Opinion in Oncology, 12/15/09    Relevance Score: 66%%

The Role of Myc-Induced Protein Synthesis in Cancer
Cancer Research, 12/09/09    Relevance Score: 66%%

Genome-wide DNA methylation profiles in precancerous conditions and cancers
Cancer Science, 11/16/09    Relevance Score: 66%%

Strategies for molecular expression profiling in bladder cancer
Cancer and Metastasis Reviews, 12/15/09    Relevance Score: 65%%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address